Adial Pharmaceuticals, Inc. Current Assets
Adial Pharmaceuticals, Inc. (ADIL) had Current Assets of $28.84 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-14
- 2026-06-30: Assets, Current $28.84M.
- 2026-03-31: Assets, Current $4.80M.
- 2025-12-31: Assets, Current $6.18M; Assets, Current as first filed $6.18M.
- 2025-09-30: Assets, Current $5.01M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $28.84M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $4.80M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $6.18M 10-Q · filed 2026-08-14 | $6.18M 10-K · filed 2026-03-05 |
| 2025-09-30 | $5.01M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $6.08M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $2.63M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $4.06M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $5.62M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $3.82M 10-Q · filed 2024-08-13 | |
| 2023-12-31 | $3.20M 10-K · filed 2025-03-04 | |
| 2023-09-30 | $1.14M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $2.05M 10-Q/A · filed 2023-10-30 | |
| 2023-03-31 | $2.96M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $4.78M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $6.77M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $9.94M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $12.96M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $6.46M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $7.99M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $5.59M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $6.17M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $5.14M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $8.17M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $9.47M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $5.94M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $7.67M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $9.50M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $10.68M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $12.05M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $4.69M 10-K · filed 2020-03-20 | |
| 2018-09-30 | $5.25M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $180.07K 10-Q · filed 2018-09-10 | |
| 2017-12-31 | $27.25K 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |